Figer A, Irmin L, Geva R, Flex D, Sulkes A, Friedman E
The Institute of Oncology, Rabin Medical Center, Belinson Campus, Petach Tikvah, Israel.
Br J Cancer. 2001 Aug 17;85(4):523-6. doi: 10.1054/bjoc.2001.1959.
The genetic basis for the majority of early onset or non-syndromic "familial" colorectal cancer (CRC) is unknown. Attenuated APC phenotype is characterized by relatively few colonic polyps, early age at onset of colon cancer compared with the general population, and inactivating germline mutations within specific regions of the APC gene. We hypothesized that germline mutations within these APC gene regions, might contribute to early onset or familial CRC susceptibility. To test this notion, we analysed 85 Israeli patients with either early onset (< 50 years at diagnosis) or familial CRC for harbouring mutations within the relevant APC gene regions: exons 1-5, exon 9 and a region within exon 15 (spanning nucleotides c.3900 to c.4034; codons 1294 to 1338) using denaturing gradient gel electrophoresis (DGGE), and all of exon 15 employing protein truncation test (PTT). No inactivating, disease-associated mutations were detected in any patient. A novel polymorphism in intron 5 was detected in 16 individuals, 8 patients were carriers of the 11307K variant, a mutation prevalent among Jewish individuals with colorectal cancer, and 4 displayed the E1317Q variant. We conclude that in Israeli individuals with early onset or familial CRC, truncating mutations in the APC gene regions associated with attenuated APC phenotype probably contribute little to disease pathogenesis.
大多数早发性或非综合征性“家族性”结直肠癌(CRC)的遗传基础尚不清楚。APC表型减弱的特征是结肠息肉相对较少,与普通人群相比结肠癌发病年龄较早,以及APC基因特定区域内的种系失活突变。我们推测,这些APC基因区域内的种系突变可能导致早发性或家族性CRC易感性。为了验证这一观点,我们分析了85例以色列早发性(诊断时<50岁)或家族性CRC患者,以检测相关APC基因区域(外显子1-5、外显子9和外显子15内的一个区域(跨越核苷酸c.3900至c.4034;密码子1294至1338))内是否存在突变,采用变性梯度凝胶电泳(DGGE)进行检测,并使用蛋白截短试验(PTT)检测外显子15的全部区域。在任何患者中均未检测到失活的、与疾病相关的突变。在16个人中检测到内含子5中的一种新型多态性,8例患者是11307K变体的携带者,这是一种在患有结直肠癌的犹太个体中普遍存在的突变,4例表现出E1317Q变体。我们得出结论,在患有早发性或家族性CRC的以色列个体中,与APC表型减弱相关的APC基因区域中的截短突变可能对疾病发病机制贡献不大。